PLG and lung cancer: To evaluate these in vitro observations in the clinical situation of this study, the levels of the 55 kDa fragment of F13A1 in platelets of patients with lung cancer and matched controls were correlated with the corresponding plasma levels of the fibrinolytic markers plasmin–α-2-antiplasmin complex and D-dimer.